High-throughput microarray for antimicrobial susceptibility testing

Area of Science:

• Biotechnology
• Microbiology
• Nanotechnology

Background:

• Antimicrobial susceptibility testing (AST) is crucial for guiding antibiotic treatment.
• Conventional AST methods can be time-consuming and require large sample volumes.
• There is a need for faster, more efficient AST platforms.

Purpose of the Study:

• To develop a novel, high-throughput, nano-scale microarray platform for AST.
• To demonstrate the platform's utility for culturing and performing AST on clinical isolates.
• To present a potentially impactful alternative to existing AST methods.

Main Methods:

• Development of a nano-scale microarray chip capable of processing 480 samples at 50 nL volume.
• Utilizing fluorescence read-out with a simple dunk-and-rinse procedure.
• Simultaneous processing of multiple samples and chips for enhanced throughput.

Main Results:

• Successful demonstration of the chip for culturing community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).
• Performance of AST against clinical isolates of CA-MRSA using the developed platform.
• The platform supports high-throughput analysis with reduced sample volume.

Conclusions:

• The novel nano-scale microarray platform offers a high-throughput, low-volume, and rapid alternative for AST.
• This technology has the potential to significantly impact microbial biotechnology.
• The platform presents a promising advancement over traditional broth microdilution and automated AST systems.